2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 21:42, 15 December 2023
, 15 December 2023→Timing for Supplementation
(→Todo) |
|||
| Line 206: | Line 206: | ||
Additionally, it's noteworthy that two MIB-626 trials utilized a twice per day administration regimen. This dosing schedule is significant because it could potentially offer more consistent NAD+ level support throughout the day, although the specific implications of this frequency in relation to circadian rhythms and overall efficacy remain an area for further research.{{pmid|35182418}}{{pmid|36740954}} | Additionally, it's noteworthy that two MIB-626 trials utilized a twice per day administration regimen. This dosing schedule is significant because it could potentially offer more consistent NAD+ level support throughout the day, although the specific implications of this frequency in relation to circadian rhythms and overall efficacy remain an area for further research.{{pmid|35182418}}{{pmid|36740954}} | ||
=== Stability === | |||
NMN appears to be stable in water; in one study 93%–99% of NMN was maintained intact in drinking water at room temperature for 7–10 days.{{pmid|21901281}} | |||
==Clinical Trials== | ==Clinical Trials== | ||